April 4-5, 2024 
San Diego Convention Center
San Diego, California

Cochairs: 

Michael A. Caligiuri, City of Hope, Duarte, California
Christiana Bardon, MPM | BioImpact Capital, Boston, Massachusetts
William N. Hait, Johnson & Johnson, New Brunswick, New Jersey

The AACR is excited to announce the launch of the Inaugural AACR Oncology Industry Partnering Event on April 4-5, 2024, in San Diego, immediately prior to the AACR Annual Meeting 2024. This event will highlight the oncology pipelines and platforms of leading pharmaceutical and biotechnology companies as well as emerging scientific themes across the biopharmaceutical industry. This oncology-focused event will bring together researchers and industry partners to share innovation strategies for drug development and present analysts and investors new partnership and licensing opportunities to advance these concepts.

A core focus of the AACR is innovation through translational science – turning clinical observations and early scientific discoveries into actionable insights and patient interventions more efficiently. Hosting the Inaugural AACR Oncology Industry Partnering Event is an important example of how the AACR is connecting clinicians and pharma, accelerating progress with cancer treatments and cures that directly benefit patients globally.  

Registration for the Inaugural AACR Oncology Industry Partnering Event is separate from registration for the AACR Annual Meeting 2024. 

Lead Supporter

Supporters